Skip to main content
Premium Trial:

Request an Annual Quote

Arbor Biosciences, Biosearch Technologies Ink Global Distribution Deal for Ag-Bio NGS Panels

NEW YORK – Arbor Biosciences announced on Wednesday an exclusive, global agreement with Biosearch Technologies to distribute Arbor's next-generation sequencing panels for ag-bio.

Under the terms of the partnership, Biosearch will provide Arbor's myBaits custom hybridization-based targeted NGS panels to commercial agricultural organizations and seed breeding companies. Arbor will continue to sell to academic and government research laboratories.

Biosearch is part of LGC Group, a UK-based company offering reference materials, reagents, and research services.

"The addition of custom hybridization-based targeted sequencing panels to our portfolio adds a critical component to our NGS offering for the ag-bio sector," Mark Dearden, VP of strategy and marketing at LGC, said in a statement.

Arbor, based in Ann Arbor, Michigan, was acquired by Chiral Technologies in January 2019. Over the last year, the firm has formed partnerships with Curio Genomics on bioinformatics for a wheat exome panel and with Medicinal Genomics for a cannabis genotyping panel.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.